Antiseizure and Neuroprotective Efficacy of Midazolam in Comparison with Tezampanel (LY293558) against Soman-Induced Status Epilepticus is a research paper published in Toxics (2022). On theSindex it has a DataRank of 0. It has been cited 13 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
CounterACT Program, National Institutes of Health, Office of the Directo
Grant: 5R21NS094131-02
Targeting the Glutamatergic System to Counteract Soman Toxicity in Immature Rats
CounterACT Program, National Institutes of Health, Office of the Directo
Grant: 1U01NS102135-01A1
Antiglutamatergic Therapy to Protect the Immature Brain Against Nerve Agents
NINDS NIH HHS
Grant: U01 NS102135
NIH HHS
Grant: 5R21NS094131-02 and 1U01NS102135-01A1
NINDS NIH HHS
Grant: R21 NS094131
FWCI
2.33
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals